Report cover image

Middle East and Africa Stem Cell Therapy Market Size- By Product Type, By Type, By Application, By End User, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Publisher SPER Market Research Pvt. Ltd.
Published Sep 04, 2024
Length 158 Pages
SKU # SPER19185812

Description

Middle East and Africa Stem Cell Therapy Market Size- By Product Type, By Type, By Application, By End User, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033


Middle East and Africa Stem Cell Therapy Market Introduction and Overview

According to SPER Market Research, ‘Middle East and Africa Stem Cell Therapy Market Size – By Product Type, By Type, By Application, By End User, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ states that the Middle East and Africa Stem Cell Therapy Market is estimated to reach USD 158.57 million by 2033 with a CAGR of 10.53%.

Stem cell therapy uses stem cells or derivatives to stimulate tissue repair in dysfunctional or wounded areas. It is the next stage of organ transplantation, replacing donor organs, which are in short supply. Adult stem cells, such as those produced from adipose tissue, bone marrow, and placental or umbilical stem cells, are found in tiny amounts in most organs.

The COVID-19 epidemic has had a tremendous influence on the healthcare sector, notably the stem cell therapy market in the Middle East and Africa. The pandemic interrupted clinical trials and healthcare systems, but it also highlighted the potential of regenerative medicine in treating COVID-19 long-term effects such as organ damage and immune system dysfunction.

Scope of the Report:

Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period: 2024-2033
Segments covered: By Product Type, By Type, By Application, By End User, By Distribution Channel
Regions covered: South Africa, Egypt, United Arab Emirates, Rest of Middle East and Africa.
Companies Covered: U.S. Stem Cell, Inc, STEMPEUTICS RESEARCH PVT LTD, Pluristem Inc, NuVasive, Inc, Mesoblast Limited, Athersys, Inc, Takeda Pharmaceutical Company Limited, Medipost Co., Ltd, JCR Pharmaceuticals Co., Ltd, Pharmicell Co., Ltd

Middle East and Africa Stem Cell Therapy Market Segmentation:

By Product Type: Based on the Product Type, Middle East and Africa Stem Cell Therapy Market is segmented as; Bone Marrow Derived Mesenchymal Cells, Placental or Umbilical Stem Cell, Adipose Tissue Derived Mesenchymal Stem Cells, and Others.

By Application: Based on the Application, Middle East and Africa Stem Cell Therapy Market is segmented as; Musculoskeletal Disorders, Acute Graft-Versus-Host Disease, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others.

By End User: Based on the End User, Middle East and Africa Stem Cell Therapy Market is segmented as; Hospitals and Surgical Centers, Therapeutic Companies, Services Companies, and Others

By Region: This research also includes data for South Africa, Egypt, United Arab Emirates, Rest of Middle East and Africa

Table of Contents

158 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Middle East and Africa Stem Cell Therapy Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Middle East and Africa Stem Cell Therapy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Middle East and Africa Stem Cell Therapy Market
7. Middle East and Africa Stem Cell Therapy Market, By Product Type (USD Million) 2020-2033
7.1. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Product Type, 2020-2026
7.2. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Product Type, 2027-2033
7.3. Bone Marrow Derived Mesenchymal Stem Cells
7.4. Placental or Umbilical Stem Cell
7.5. Adipose Tissue Derived Mesenchymal Stem Cells
7.6. Others
8. Middle East and Africa Stem Cell Therapy Market, By Type (USD Million) 2020-2033
8.1. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Type, 2020-2026
8.2. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Type, 2027-2033
8.3. Allogeneic Stem Cell Therapy
8.4. Autologous Stem Cell Therapy
9. Middle East and Africa Stem Cell Therapy Market, By Application (USD Million) 2020-2033
9.1. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Application, 2020-2026
9.2. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Application, 2027-2033
9.3. Musculoskeletal Disorders
9.4. Wounds and Injuries
9.5. Acute Graft-Versus-Host Disease (AGVHD)
9.6. Surgeries
9.7. Gastrointestinal Diseases
9.8. Cardiovascular Diseases
9.9. Others
10. Middle East and Africa Stem Cell Therapy Market, By End User (USD Million) 2020-2033
10.1. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By End User, 2020-2026
10.2. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By End User, 2027-2033
10.3. Hospitals and Surgical Centers
10.4. Therapeutic Companies
10.5. Services Companies
10.6. Others
11. Middle East and Africa Stem Cell Therapy Market, By Distribution Channel (USD Million) 2020-2033
11.1. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Distribution Channel, 2020-2026
11.2. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Distribution Channel, 2027-2033
11.3. Direct Tenders
11.4. Third Party Distributors
12. Middle East and Africa Stem Cell Therapy Market Forecast, 2020-2033 (USD Million)
12.1. Middle East and Africa Stem Cell Therapy Market Size and Market Share
13. Middle East and Africa Stem Cell Therapy Market, By Region, 2020-2033 (USD Million)
13.1. Middle East and Africa Stem Cell Therapy Market Size and Market Share By Region (2020-2026)
13.2. Middle East and Africa Stem Cell Therapy Market Size and Market Share By Region (2027-2033)
13.3. South Africa
13.4. Egypt
13.5. United Arab Emirates
13.6. Rest of Middle East and Africa
14. Company Profile
14.1. U.S. Stem Cell, Inc
14.1.1. Company details
14.1.2. Financial outlook
14.1.3. Product summary
14.1.4. Recent developments
14.2. STEMPEUTICS RESEARCH PVT LTD
14.2.1. Company details
14.2.2. Financial outlook
14.2.3. Product summary
14.2.4. Recent developments
14.3. Pluristem Inc
14.3.1. Company details
14.3.2. Financial outlook
14.3.3. Product summary
14.3.4. Recent developments
14.4. NuVasive, Inc
14.4.1. Company details
14.4.2. Financial outlook
14.4.3. Product summary
14.4.4. Recent developments
14.5. Mesoblast Limited
14.5.1. Company details
14.5.2. Financial outlook
14.5.3. Product summary
14.5.4. Recent developments
14.6. Athersys, Inc
14.6.1. Company details
14.6.2. Financial outlook
14.6.3. Product summary
14.6.4. Recent developments
14.7. Takeda Pharmaceutical Company Limited
14.7.1. Company details
14.7.2. Financial outlook
14.7.3. Product summary
14.7.4. Recent developments
14.8. Medipost Co., Ltd
14.8.1. Company details
14.8.2. Financial outlook
14.8.3. Product summary
14.8.4. Recent developments
14.9. JCR Pharmaceuticals Co., Ltd
14.9.1. Company details
14.9.2. Financial outlook
14.9.3. Product summary
14.9.4. Recent developments
14.10. Pharmicell Co., Ltd
14.10.1. Company details
14.10.2. Financial outlook
14.10.3. Product summary
14.10.4. Recent developments
14.11. Hope Biosciences
14.11.1. Company details
14.11.2. Financial outlook
14.11.3. Product summary
14.11.4. Recent developments
14.12. BrainStorm Cell Therapeutics Inc
14.12.1. Company details
14.12.2. Financial outlook
14.12.3. Product summary
14.12.4. Recent developments
14.13. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us